Back to Search
Start Over
Use of REGEN-COV in children after heart transplantation for treatment and post-exposure prophylaxis of COVID-19.
- Source :
-
Cardiology in the young [Cardiol Young] 2023 Mar; Vol. 33 (3), pp. 496-497. Date of Electronic Publication: 2022 Jul 07. - Publication Year :
- 2023
-
Abstract
- COVID-19 pandemic continues to evolve and new variants like Delta and Omicron have been discovered. REGEN-COV is a recombinant human monoclonal antibody to the spike protein of SARS-CoV-2 which received emergency use authorisation for treatment and post-exposure prophylaxis in patients with high risk of progression to severe disease. We review our experience with use of REGEN-COV in paediatric heart transplant patients.
Details
- Language :
- English
- ISSN :
- 1467-1107
- Volume :
- 33
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Cardiology in the young
- Publication Type :
- Academic Journal
- Accession number :
- 35798332
- Full Text :
- https://doi.org/10.1017/S1047951122002190